XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 17,438
R4B: 0
R5: 438
R6: 0

By Authority

none: 1,998
hl7: 16,400
national: 2

Start Prev Rows 11800 - 12000 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1008	Patient Reason	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1010	Cancer	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1011	Occupational Therapy Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1012	Patient Provider Interaction	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1018	Psych Visit for Family Psychotherapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1023	Behavioral or Neuropsych Assessment	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1026	Radiation Treatment Management	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1027	Chemotherapy Administration	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1028	Standardized Pain Assessment Tool	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1090	Moderate or Severe LVSD	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1091	Left Ventricular Systolic Dysfunction	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1092	Moderate or Severe	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1134	Ejection Fraction	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1139	ACE Inhibitor or ARB or ARNI	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1140	Patient Reason for ACE Inhibitor or ARB Decline	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1141	Psychoanalysis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1151	Renal Failure Due to ACE Inhibitor	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1170	Tobacco User	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1174	Beta Blocker Therapy	active	2021-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1176	Heart Rate	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1177	Allergy to Beta Blocker Therapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1178	Intolerance to Beta Blocker Therapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1184	Beta Blocker Therapy for LVSD	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1187	Group Psychotherapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1189	Tobacco Non User	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1190	Tobacco Use Cessation Pharmacotherapy	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1193	Cardiac Pacer	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1211	Allergy to ACE Inhibitor or ARB	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1212	Intolerance to ACE Inhibitor or ARB	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1240	Annual Wellness Visit	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1241	Acute and Subacute Iridocyclitis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1251	Macular Exam	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1259	Limited Life Expectancy	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1278	Tobacco Use Screening	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1283	Level of Severity of Retinopathy Findings	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1285	Ophthalmological Services	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1320	Macular Edema Findings Present	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1332	Cognitive Assessment	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1333	Cup to Disc Ratio	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1334	Optic Disc Exam for Structural Abnormalities	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1409	Burn Confined to Eye and Adnexa	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1410	Cataract Secondary to Ocular Disorders	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1411	Cataract Surgery	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1412	Cataract Congenital	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1413	Cataract Mature or Hypermature	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1414	Cataract Posterior Polar	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1415	Certain Types of Iridocyclitis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1416	Chronic Iridocyclitis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1417	Cloudy Cornea	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1418	Corneal Edema	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1419	Disorders of Cornea Including Corneal Opacity	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1423	Glaucoma	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1424	Hereditary Corneal Dystrophies	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1426	Hypotony of Eye	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1427	Injury to Optic Nerve and Pathways	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1428	Central Corneal Ulcer	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1430	Open Wound of Eyeball	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1432	Pathologic Myopia	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1433	Posterior Lenticonus	active	2021-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1438	Retrolental Fibroplasias	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1443	Traumatic Cataract	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1444	Uveitis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1445	Vascular Disorders of Iris and Ciliary Body	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1446	Visual Field Defects	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1448	Amblyopia	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1450	Choroidal Degenerations	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1451	Choroidal Detachment	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1452	Choroidal Hemorrhage and Rupture	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1453	Degeneration of Macula and Posterior Pole	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1454	Degenerative Disorders of Globe	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1455	Diabetic Macular Edema	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1457	Disorders of Optic Chiasm	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1458	Disorders of Visual Cortex	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1459	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1460	Focal Chorioretinitis and Focal Retinochoroiditis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1461	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1462	Hereditary Choroidal Dystrophies	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1463	Hereditary Retinal Dystrophies	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1465	Nystagmus and Other Irregular Eye Movements	active	2021-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1466	Optic Atrophy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1467	Optic Neuritis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1468	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1469	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1471	Other Disorders of Optic Nerve	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1473	Other Endophthalmitis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1475	Prior Penetrating Keratoplasty	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1477	Purulent Endophthalmitis	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1478	Retinal Detachment with Retinal Defect	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1479	Retinal Vascular Occlusion	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1480	Other Proliferative Retinopathy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1482	Separation of Retinal Layers	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1483	Visual Acuity 20/40 or Better	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1491	Major Depressive Disorder Active	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1492	Psych Visit Diagnostic Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1496	Psych Visit Psychotherapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1530	Speech and Hearing Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1558	Morgagnian Cataract	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1559	Macular Scar of Posterior Polar	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1560	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1561	Medications for Above Normal BMI	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1562	Medications for Below Normal BMI	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1563	Underweight	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1566	Adult Depression Medications	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1567	Adolescent Depression Medications	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1568	Follow Up for Adult Depression	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1569	Follow Up for Adolescent Depression	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1570	Referral for Adolescent Depression	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1571	Referral for Adult Depression	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1572	High Intensity Statin Therapy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1573	LDL Cholesterol	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1574	Low Intensity Statin Therapy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1575	Moderate Intensity Statin Therapy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1576	Outpatient Encounters for Preventive Care	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1578	Follow Up Within 4 Weeks	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1580	Referral to Primary Care or Alternate Provider	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1581	Lifestyle Recommendation	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1582	Patient Declined	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1583	Referral or Counseling for Alcohol Consumption	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1584	Hospice Care Ambulatory	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.3000	Metformin	active	2019-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.319	Prostate Cancer	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.320	Bone Scan	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.326	Primary Open Angle Glaucoma	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.327	Diabetic Retinopathy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.353	End Stage Renal Disease	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.362	Asthma	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.366	Arrhythmia	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.367	Atrioventricular Block	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.368	Cardiac Pacer in Situ	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.369	Coronary Artery Disease No MI	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.370	Hypotension	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.371	Cardiac Surgery	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.376	Heart Failure	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.378	Pregnancy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.398	Prostate Cancer Treatment	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.399	Salvage Therapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.401	Prostate Specific Antigen Test	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.403	Initial Myocardial Infarction	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.412	Bradycardia	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.451	Pain Warranting Further Investigation for Prostate Cancer	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.471	Bilateral Oophorectomy	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.485	Chemotherapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.509	Tobacco Use Cessation Counseling	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1498	Medications for Above Normal BMI	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1499	Medications for Below Normal BMI	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1519	Follow Up for Above Normal BMI	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1523	Follow Up for Above Normal BMI	active	2017-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1524	Follow Up for BMI Outside Normal Parameters	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1525	Follow Up for Above Normal BMI	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1526	Follow Up for Above Normal BMI	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1527	Referrals Where Weight Assessment May Occur	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1528	Follow Up for Below Normal BMI	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1549	Follow Up for Below Normal BMI	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1550	Follow Up for Below Normal BMI	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1551	Follow Up for Below Normal BMI	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1578	Palliative Care	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1579	Palliative or Hospice Care	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1608	Encounter to Document Medications	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1609	Encounter to Document Medications	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1610	Referrals Where Weight Assessment May Occur	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1751	Encounter to Evaluate BMI	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1834	Encounter to Document Medications	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1917	Encounter to Document Medications	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.695	Encounter to Evaluate BMI	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.885	Encounter to Evaluate BMI	active	2018-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.886	Encounter to Evaluate BMI	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1475	Referral to Primary Care or Alternate Provider	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1476	Pharmacologic Therapy for Hypertension	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1482	Laboratory Tests for Hypertension	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1497	Encounter to Screen for Blood Pressure	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1508	Lifestyle Recommendation	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1509	Weight Reduction Recommended	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1510	Weight Reduction Recommended	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1511	Dietary Recommendations	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1512	Dietary Recommendations	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1514	Dietary Recommendations	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1515	Dietary Recommendations	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1516	Exercise Class	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1518	Recommendation to Increase Physical Activity	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1537	Follow Up Within 4 Weeks	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1538	Encounter to Screen for Depression	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1914	Encounter to Screen for Depression	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1915	Encounter to Screen for Depression	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1916	Encounter to Screen for Depression	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1918	Encounter to Screen for Blood Pressure	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.192	Encounter to Screen for Blood Pressure	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1920	Encounter to Screen for Blood Pressure	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2387	Overweight or Obese	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2388	Underweight	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2395	Finding of Hypertension	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2462	Laboratory Tests for Hypertension	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2466	Dental Tooth Extraction	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.259	Diagnosis of Hypertension	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.261	Diagnosis of Hypertension	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.263	Diagnosis of Hypertension	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.467	Follow Up for Adolescent Depression	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.468	Follow Up for Adult Depression	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.469	Adolescent Depression Medications	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.470	Adult Depression Medications	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.537	Referral for Adolescent Depression	active	2023-02	hl7